No Data
No Data
H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)
Assembly Biosciences Q1 EPS $(1.66) Beats $(3.24) Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(1.66) per share which beat the analyst consensus estimate of $(3.24) by 48.77 percent. This is a 62.61 percent increase over losses of
Assembly Biosciences | 10-Q: Quarterly report
Assembly Biosciences 1Q Loss $9.08M >ASMB
Assembly Biosciences 1Q Loss $9.08M >ASMB
Assembly Biosciences 1Q Loss/Shr $1.66 >ASMB
Assembly Biosciences 1Q Loss/Shr $1.66 >ASMB
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)
No Data